Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease

Experimental and Molecular Pathology

Volumn 79, Issue 2, 2005, Pages 136-145

  Niculescu, Florin ^a   Niculescu, Teodora ^b   Nguyen, Phuong ^a   Puliaev, Roman ^a   Papadimitriou, John C ^b   Gaspari, Anthony ^b   Rus, Horea ^b,c   Via, Charles S ^a,c,d  

^a Division of Rheumatology and Clinical Immunology   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c VAMHCS   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; Fas; GVHD; In vivo animal models; T lymphocytes

Indexed keywords

COMPLEMENT COMPONENT C5; FAS LIGAND;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; GRAFT REJECTION; HISTOLOGY; HISTOPATHOLOGY; INNATE IMMUNITY; KIDNEY; LUNG; MALE; MOUSE; NICK END LABELING; NONHUMAN; SPLEEN; T LYMPHOCYTE; TISSUE INJURY;

ANIMALS; APOPTOSIS; COMPLEMENT MEMBRANE ATTACK COMPLEX; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KIDNEY; LIVER; LUNG; MALE; MICE; SKIN; SPLEEN;

ANIMALIA; MURINAE;

EID: 24344481264     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2005.03.007     Document Type: Article

References (46)

1. S. Aractingi, and O. Chosidow Cutaneous graft-versus-host disease Arch. Dermatol. 134 1998 602 612
2. M.B. Baker, N.H. Altman, E.R. Podack, and R.B. Levy The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice J. Exp. Med. 183 1996 2645 2656
3. P. Bobe, D. Bonardelle, M. Reynes, F. Godeau, J. Mahiou, V. Joulin, and N. Kiger Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease J. Immunol. 159 1997 4197 4204
4. M.Y. Braun, B. Lowin, L. French, H. Acha-Orbea, and J. Tschopp Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease J. Exp. Med. 183 1996 657 661
5. R.J. Chang, and S.H. Lee Effects of interferon-gamma and tumor necrosis factor-alpha on the expression of an Ia antigen on a murine macrophage cell line J. Immunol. 137 1986 2853 2856
6. R.A. Clift, C.D. Buckner, F.R. Appelbaum, S.I. Bearman, F.B. Petersen, L.D. Fisher, C. Anasetti, P. Beatty, W.I. Bensinger, and K. Doney Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens Blood 76 1990 1867 1871
7. R.A. Colvin Renal transplant pathology J.C. Jennette J.L. Olson M.M. Schwartz F.G. Silva Heptinstal Pathology of the Kidney 1998 Lippincott-Raven Philadelphia 1417 1418
8. U.S. Gaipl, S. Kuenkele, R.E. Voll, T.D. Beyer, W. Kolowos, P. Heyder, J.R. Kalden, and M. Herrmann Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death Cell Death Differ. 8 2001 327 334
9. T. Hahn, C. Rondeau, A. Shaukat, V. Jupudy, A. Miller, A.R. Alam, M.R. Baer, B. Bambach, Z. Bernstein, A.A. Chanan-Khan, M.S. Czuczman, J. Slack, M. Wetzler, B.K. Mookerjee, J. Silva, and P.L. McCarthy Jr. Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients Bone Marrow Transplant. 32 2003 405 410
10. F.T. Hakim, S.O. Sharrow, S. Payne, and G.M. Shearer Repopulation of host lymphohematopoietic systems by donor cells during graft-versus-host reaction in unirradiated adult F1 mice injected with parental lymphocytes J. Immunol. 146 1991 2108 2115
11. K. Hattori, T. Hirano, H. Miyajima, N. Yamakawa, M. Tateno, K. Oshimi, N. Kayagaki, H. Yagita, and K. Okumura Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies Blood 91 1998 4051 4055
12. G.R. Hill, and J.L. Ferrara The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation Blood 95 2000 2754 2759
13. C.C. Hofmeister, A. Quinn, K.R. Cooke, P. Stiff, B. Nickoloff, and J.L. Ferrara Graft-versus-host disease of the skin: life and death on the epidermal edge Biol. Blood Marrow Transplant. 10 2004 366 372
14. Y. Kataoka, T. Iwasaki, T. Kuroiwa, Y. Seto, N. Iwata, N. Hashimoto, A. Ogata, T. Hamano, and E. Kakishita The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease Immunology 103 2001 310 318
15. E. Kubota, H. Ishikawa, and K. Saito Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression J. Immunol. 131 1983 1142 1148
16. D.K. Madtes, and S.W. Crawford Lung injuries associated with graft-versus-host reactions J.L. Ferrara H.J. Deeg S.J. Burakoff Graft-vs.-Host Disease 1997 Marcel Dekker, Inc. New York 425 446
17. D. Mevorach, J.O. Mascarenhas, D. Gershov, and K.B. Elkon Complement-dependent clearance of apoptotic cells by human macrophages J. Exp. Med. 188 1998 2313 2320
18. R. Miralbell, S. Bieri, B. Mermillod, C. Helg, G. Sancho, B. Pastoors, A. Keller, J.M. Kurtz, and B. Chapuis Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease J. Clin. Oncol. 14 1996 579 585
19. M. Murai, H. Yoneyama, A. Harada, Z. Yi, C. Vestergaard, B. Guo, K. Suzuki, H. Asakura, and K. Matsushima Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease J. Clin. Invest. 104 1999 49 57
20. S. Nakashima, Z. Qian, S. Rahimi, B.A. Wasowska, and W.M. Baldwin III Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection J. Immunol. 169 2002 4620 4627
21. A.J. Nauta, M.R. Daha, O. Tijsma, B. van de Water, F. Tedesco, and A. Roos The membrane attack complex of complement induces caspase activation and apoptosis Eur. J. Immunol. 32 2002 783 792
22. A.J. Nauta, L.A. Trouw, M.R. Daha, O. Tijsma, R. Nieuwland, W.J. Schwaeble, A.R. Gingras, A. Mantovani, E.C. Hack, and A. Roos Direct binding of C1q to apoptotic cells and cell blebs induces complement activation Eur. J. Immunol. 32 2002 1726 1736
23. F. Niculescu, T. Niculescu, and H. Rus C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis Exp. Mol. Pathol. 76 2004 17 23
24. C. Noel, M. Hazzan, M.P. Noel-Walter, and J.P. Jouet Renal failure and bone marrow transplantation Nephrol. Dial. Transplant. 13 1998 2464 2466
25. S.T. Pals, T. Radaszkiewicz, L. Roozendaal, and E. Gleichmann Chronic progressive polyarthritis and other symptoms of collagen vascular disease induced by graft-vs-host reaction J. Immunol. 134 1985 1475 1482
26. F. Paris, Z. Fuks, A. Kang, P. Capodieci, G. Juan, D. Ehleiter, A. Haimovitz-Friedman, C. Cordon-Cardo, and R. Kolesnick Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice Science 293 2001 293 297
27. J.S. Pober, C.G. Orosz, M.L. Rose, and C.O. Savage Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 61 1996 343 349
28. S. Rahimi, Z. Qian, J. Layton, K. Fox-Talbot, W.M. Baldwin III, and B.A. Wasowska Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts Am. J. Transplant 4 2004 326 334
29. P. Reddy Pathophysiology of acute graft-versus-host disease Hematol. Oncol. 21 2003 149 161
30. P. Reddy, and J.L. Ferrara Immunobiology of acute graft-versus-host disease Blood Rev. 17 2003 187 194
31. P. Reddy, T. Teshima, M. Kukuruga, R. Ordemann, C. Liu, K. Lowler, and J.L. Ferrara Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis J. Exp. Med. 194 2001 1433 1440
32. A.G. Rolink, S.T. Pals, and E. Gleichmann Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease: II. F1 recipients carrying mutations at H-2K and/or I-A J. Exp. Med. 157 1983 755 771
33. H.G. Rus, F. Niculescu, and R. Vlaicu Co-localization of terminal C5b-9 complement complexes and macrophages in human atherosclerotic arterial walls Immunol. Lett. 19 1988 27 32
34. H.G. Rus, F. Niculescu, and R. Vlaicu The relationship between macrophages and C5b-9 complement complexes in human atherosclerosis Clin. Immunol. Immunopathol. 48 1988 307 316
35. C. Schmaltz, O. Alpdogan, K.J. Horndasch, S.J. Muriglan, B.J. Kappel, T. Teshima, J.L. Ferrara, S.J. Burakoff, and M.R. van den Brink Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect Blood 97 2001 2886 2895
36. H.M. Shulman, P. Sharma, D. Amos, L.F. Fenster, and G.B. McDonald A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation Hepatology 8 1988 463 470
37. A. Shustov, P. Nguyen, F.D. Finkelman, K.B. Elkon, and C.S. Via Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production J. Immunol. 161 1998 2848 2855
38. A. Shustov, I. Luzina, P. Nguyen, J.C. Papadimitriou, B. Handwerger, K.B. Elkon, and C.S. Via Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity J. Clin. Invest. 106 2000 R39 R47
39. D.C. Snover, A.H. Filipovich, N.K. Ramsay, S.A. Weisdorf, and J.H. Kersey Graft-versus-host-disease-like histopathological findings in pre-bone-marrow transplantation biopsies of patients with severe T cell deficiency Transplantation 39 1985 95 97
40. M. Sykes, F. Preffer, S. McAfee, S.L. Saidman, D. Weymouth, D.M. Andrews, C. Colby, R. Sackstein, D.H. Sachs, and T.R. Spitzer Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation Lancet 353 1999 1755 1759
41. T. Teshima, and J.L. Ferrara Understanding the alloresponse: new approaches to graft-versus-host disease prevention Semin. Hematol. 39 2002 15 22
42. I. Verbovetski, H. Bychkov, U. Trahtemberg, I. Shapira, M. Hareuveni, O. Ben-Tal, I. Kutikov, O. Gill, and D. Mevorach Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7 J. Exp. Med. 196 2002 1553 1561
43. C.S. Via, and G.M. Shearer T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease Immunol. Today 9 1988 207 213
44. C.S. Via, S.O. Sharrow, and G.M. Shearer Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease J. Immunol. 139 1987 1840 1849
45. T. Wekerle, J. Kurtz, H. Ito, J.V. Ronquillo, V. Dong, G. Zhao, J. Shaffer, M.H. Sayegh, and M. Sykes Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment Nat. Med. 6 2000 464 469
46. C.Q. Xun, J.S. Thompson, C.D. Jennings, S.A. Brown, and M.B. Widmer Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice Blood 83 1994 2360 2367